During the last session, Humacyte Inc (NASDAQ:HUMA)’s traded shares were 0.9 million, with the beta value of the company hitting 1.42. At the end of
In the last trading session, 3.09 million shares of the Humacyte Inc (NASDAQ:HUMA) were traded, and its beta was 1.43. Most recently the company’s share
In the last trading session, 2.99 million Humacyte Inc (NASDAQ:HUMA) shares changed hands as the company’s beta touched 1.49. With the company’s per share price
In the last trading session, 6.3 million Humacyte Inc (NASDAQ:HUMA) shares changed hands as the company’s beta touched 1.45. With the company’s per share price
In last trading session, Humacyte Inc (NASDAQ:HUMA) saw 4.28 million shares changing hands with its beta currently measuring 1.47. Company’s recent per share price level
Humacyte Inc (NASDAQ:HUMA) has a beta value of 1.47 and has seen 3.18 million shares traded in the last trading session. The company, currently valued
During the last session, Humacyte Inc (NASDAQ:HUMA)’s traded shares were 3.62 million, with the beta value of the company hitting 1.45. At the end of
In the last trading session, 1.78 million shares of the Humacyte Inc (NASDAQ:HUMA) were traded, and its beta was 1.45. Most recently the company’s share
In the last trading session, 2.7 million shares of the Humacyte Inc (NASDAQ:HUMA) were traded, and its beta was 1.45. Most recently the company’s share
Humacyte Inc (NASDAQ:HUMA)’s traded shares stood at 2.64 million during the last session, with the company’s beta value hitting 1.45. At the close of trading,
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
